Risk of pancreatic cancer after eradication treatment of Helicobacter pylori
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2025.116192 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Anna-Klara Wiklund und 8 weiteren Autor:innen. Beteiligte Einrichtung: Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sw…. Hauptthemen laut MEDLINE: Helicobacter Infections, Pancreatic Neoplasms, Helicobacter pylori, Anti-Bacterial Agents. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sjöberg Foundation, Nordic Cancer Union.
Abstract (Originalsprache)
OBJECTIVES: Helicobacter pylori infection seems to increase the risk of developing pancreatic cancer, but it is unknown whether eradication treatment of this bacterium changes this risk. We hypothesized that the increased risk of pancreatic cancer among individuals infected with Helicobacter pylori decreases over time after eradication treatment. METHODS: This multinational and population-based cohort study, using prospectively collected nationwide register data from 1995 to 2019, included all adults who received eradication treatment for Helicobacter pylori in Denmark, Finland, Iceland, Norway, or Sweden. Standardized incidence ratios (SIR) with 95 % confidence intervals (95 %CI) were calculated by dividing the incidence rates of pancreatic cancer in the eradication treatment cohort by that of the entire populations of the corresponding age, sex, calendar year, and country. The main outcome was changes in SIR over time after eradication treatment. RESULTS: During up to 24 years of follow-up of 661,827 participants and 5494,255 person-years in the eradication treatment cohort, 2331 participants developed pancreatic cancer. The risk of pancreatic cancer was increased during the first 1-5 years after eradication treatment (SIR 1.14, 95 % CI 1.07-1.21), after which it decreased and became similar to the level of the background population 6-10 years (SIR 0.99, 95 % CI 0.92-1.07) and 11-24 years (SIR 1.00, 95 % CI 0.92-1.08) after eradication treatment. CONCLUSION: The elevated risk of developing pancreatic cancer among individuals with Helicobacter pylori infection seems to decrease after eradication treatment, reaching the risk estimates of the background population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Surgery, Stockholm South Hospital, Department of C…
- Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
- The Icelandic Cancer Registry, Reykjavik, Iceland.
- Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; HUNT Research Center, Department of Public Health and Nursing, N…
- Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Surgery, Oulu University Hospital, University of O…
Förderung
- Sjöberg Foundation
- Nordic Cancer Union
Zitieren
APA
Wiklund, A. K., Santoni, G., Radkiewicz, C., Xie, S., Birgisson, H., Ness-Jensen, E., von Euler-Chelpin, M., Kauppila, J. H., & Lagergren, J. (2026). Risk of pancreatic cancer after eradication treatment of Helicobacter pylori. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116192
Vancouver
Wiklund AK, Santoni G, Radkiewicz C, Xie S, Birgisson H, Ness-Jensen E, et al. Risk of pancreatic cancer after eradication treatment of Helicobacter pylori. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2025.116192
BibTeX
@article{Wiklund2026,
author = {Wiklund, Anna-Klara and Santoni, Giola and Radkiewicz, Cecilia and Xie, Shaohua and Birgisson, Helgi and Ness-Jensen, Eivind and von Euler-Chelpin, My and Kauppila, Joonas H and Lagergren, Jesper},
title = {Risk of pancreatic cancer after eradication treatment of Helicobacter pylori},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2025.116192}
}
EUVIMED